Search Results for "opioids"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for opioids. Results 131 to 140 of 186 total matches.

Drugs and Devices for Weight Management

   
The Medical Letter on Drugs and Therapeutics • Aug 04, 2025  (Issue 1734)
-69% 209.00 Qsymia (Vivus) 15/92 mg ER caps PO qAM12 Opioid Antagonist/Antidepressant Combination ...
Overweight is generally defined as a body mass index (BMI) between 25 and 29.9 kg/m2 in adults. A BMI ≥30 is considered obese (criteria differ slightly in Asian patients). In patients with an elevated BMI, a 5-10% reduction in weight has been associated with a reduction in the risk of developing type 2 diabetes, hypertension, and dyslipidemia. Diet, exercise, and behavior modification are the traditional methods for losing weight, but they are often inadequate; the American College of Cardiology no longer recommends that all patients try lifestyle modification alone before adding...
Med Lett Drugs Ther. 2025 Aug 4;67(1734):121-8   doi:10.58347/tml.2025.1734a |  Show IntroductionHide Introduction

In Brief: Palladone Withdrawn

   
The Medical Letter on Drugs and Therapeutics • Aug 01, 2005  (Issue 1214)
Oramorph opioids MS Contin Morphine Kadian Hydromorphone ...
The Medical Letter review of Palladone (hydromorphone HCl) extended-release capsules (March 14, 2005) warned that a lethal dose could be released if the new formulation was taken with alcohol. Because of that risk, the FDA asked the manufacturer (Purdue) to withdraw the drug from the market (FDA News. July 13, 2005; FDC Reports – “The Pink Sheet” July 18, 2005; 67:3).
Med Lett Drugs Ther. 2005 Aug 1;47(1214):61 |  Show IntroductionHide Introduction

Table: Some Drug Interactions with Drugs for IBD (online only)

   
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023  (Issue 1680)
opioids) or noradrenergic drugs with ozanimod could result in hypertensive crisis and is not recommended ...
View the Table: Some Drug Interactions with Drugs for IBD
Med Lett Drugs Ther. 2023 Jul 10;65(1680):e114   doi:10.58347/tml.2023.1680c |  Show IntroductionHide Introduction

Gabapentin (Neurontin) for Chronic Pain

   
The Medical Letter on Drugs and Therapeutics • Apr 12, 2004  (Issue 1180)
not respond as well as other types of pain to standard doses of opioids. Anticonvulsants are often used ...
Gabapentin (Neurontin - Pfizer), which has been available in the US since 1994, is approved by the FDA only for treatment of partial epilepsy and postherpetic neuralgia, but is widely used off-label for a number of other indications, especially neuropathic pain syndromes. According to one report, among Medicaid recipients in Florida receiving gabapentin, 71% of prescriptions were for chronic pain and 8% for seizures and neuralgia ("The Pink Sheet" February 2, 2004; 66:30).
Med Lett Drugs Ther. 2004 Apr 12;46(1180):29-31 |  Show IntroductionHide Introduction

Uterine Artery Embolization for Fibroids

   
The Medical Letter on Drugs and Therapeutics • Apr 11, 2005  (Issue 1206)
and administration of parenteral opioids. UAE is generally not recommended for women who have not completed ...
Uterine artery embolization (UAE) is an increasingly used alternative to surgery for treatment of uterine fibroids.
Med Lett Drugs Ther. 2005 Apr 11;47(1206):31-2 |  Show IntroductionHide Introduction

Drugs for Anxiety Disorders

   
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023  (Issue 1682)
depressants can result in additive CNS depression. Benzodiazepines are often used concurrently with opioids ...
Anxiety disorders (generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobias) are the most common form of psychiatric illness. They can be treated effectively with cognitive behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8   doi:10.58347/tml.2023.1682a |  Show IntroductionHide Introduction

Clarification: Half-Life of Heroin

   
The Medical Letter on Drugs and Therapeutics • Feb 29, 2016  (Issue 1489)
concern that a statement in our article Naloxone (Narcan) Nasal Spray for Opioid Overdose (Med Lett ...
A reader expressed concern that a statement in our article Naloxone (Narcan) Nasal Spray for Opioid Overdose (Med Lett Drugs Ther 2016; 58:1) might be misleading. We stated that heroin has a half-life of 2-6 minutes, which is correct, but heroin is a prodrug that is rapidly metabolized to 6-acetylmorphine and morphine. The risk of respiratory depression is related to those active metabolites, and it may persist well beyond the clearance of heroin from the blood.
Med Lett Drugs Ther. 2016 Feb 29;58(1489):32 |  Show IntroductionHide Introduction

Drug Interactions

   
The Medical Letter on Drugs and Therapeutics • Jun 08, 2003  (Issue 1158)
(Versed*), triazolam (Halcion*) Opioids: alfentanyl (Alfenta*),fentanyl(Sublimaze*), sufentanil (Sufenta ...
Changes caused by one drug in the absorption, distribution, metabolism or excretion of another may lead to a pharmacokinetic adverse drug interaction (DN Juurlink et al, JAMA 2003; 289:1652). Additive drug interactions, such as vasodilation caused by both sildenafil (Viagra) and nitrates, can also have adverse effects.
Med Lett Drugs Ther. 2003 Jun 8;45(1158):46-8 |  Show IntroductionHide Introduction

Dextromethorphan/Bupropion (Auvelity) for Depression

   
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022  (Issue 1666)
(Contrave) is approved for weight management. PHARMACOLOGY — Dextromethorphan is an analog of the opioid ...
The FDA has approved an extended-release fixed-dose combination of dextromethorphan and bupropion (Auvelity – Axsome) for treatment of major depressive disorder (MDD) in adults.
Med Lett Drugs Ther. 2022 Dec 26;64(1666):201-3 |  Show IntroductionHide Introduction

Drugs Past Their Expiration Date

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 2026  (Issue 1745)
distributed to first responders and family members of opioid users, who may retain these products beyond ...
Healthcare providers are often asked if drugs can be used past their expiration date. Because of legal restrictions and liability concerns, manufacturers do not sanction such use and usually do not comment on the safety or effectiveness of their products beyond the date on the label. Since our last article on this subject, more data have become available.
Med Lett Drugs Ther. 2026 Jan 5;68(1745):5-7   doi:10.58347/tml.2026.1745c |  Show IntroductionHide Introduction